Clinical Trial Update: Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASH [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the antioxidant activity of Heptex in patients with nonalcoholic steatohepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Heptex

Snippet

Sponsor: Natural Wellness Egypt | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED